PharmaLeaders.com

Under the terms of the partnership deal between the companies, Hyloris will receive a share on any revenues related to product, such as royalties, license fees, milestone payments, The post AFT and Salus Pharmaceuticals sign agreement for pain treatment Maxigesic IV appeared first on Pharmaceutical … [Read More...]

Initially, the FDA approved Benlysta for the treatment of active systemic lupus erythematosus (SLE). GSK noted that it is the first and only approved biologic for SLE as The post GSK receives orphan drug designation for Benlysta to treat systemic sclerosis appeared first on Pharmaceutical Business … [Read More...]

Serving as the primary IND for TScan’s solid tumour programme, T-Plex will enable customised combinations of T cell receptor (TCR)-engineered T cell therapies (TCR-T) to be given to The post TScan Therapeutics receives FDA clearance for IND applications appeared first on Pharmaceutical Business … [Read More...]

AB-101 is a non-genetically modified, cord blood-derived, allogeneic, cryopreserved, ADCC-enhancing NK cell therapy candidate for use along with monoclonal antibodies or innate-cell engagers in the out-patient environment. Artiva The post US FDA grants fast track designation to Artiva’s lead … [Read More...]